The effects of exercise training on metabolic and morphological outcomes for people living with HIV: A systematic review of randomised controlled trials

HIV Clinical Trials

Volumn 11, Issue 5, 2010, Pages 270-282

  Fillipas, S ^a,b   Cherry, C L ^b,c,d   Cicuttini, F ^b,e   Smirneos, L ^f   Holland, A E ^a,g  

^a Physiotherapy Department   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Infectious Diseases Unit   (Australia)

^d BURNET INSTITUTE   (Australia)

^e Rheumatology   (Australia)

^f Ian Potter Foundation   (Australia)

^g LA TROBE UNIVERSITY   (Australia)

Author keywords

aerobic exercise; HIV; progressive resistive exercise; randomised controlled trial

Indexed keywords

GLUCOSE; LIPID;

AEROBIC EXERCISE; ARTICLE; BODY FAT; BODY MASS; BODY WEIGHT; BONE DENSITY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIPID BLOOD LEVEL; METABOLISM; MORPHOLOGY; OBESITY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKINFOLD THICKNESS; SUBCUTANEOUS FAT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; EXERCISE; FEMALE; HIV; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKINFOLD THICKNESS; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 79251636237     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/hct1105-270     Document Type: Article

References (52)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338(13):853-860.
2. Collaboration ATC. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372:293-299.
3. Anuurad E, Semrad A, Berglund L. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease. Metab Syndr Relat Disord. 2009;7(5):401-410.
4. Carr A, Samaras K, Chisholm DJ, Cooper DA. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet. 1998;351(9119):1881-1883. (Pubitemid 28279721)
5. Grinspoon S, Carr A. Cardiovascular risk and bodyfat abnormalities in HIV-infected adults. N Engl J Med. 2005;352(1):48-62. (Pubitemid 40075680)
6. Grund B, Peng G, Gibert CL, et al. Continuous antiretroviral therapy decreases bone mineral density. AIDS (Lond). 2009;23(12):1519-1529.
7. Hoy J, Lewin S, Post J, Street A, eds. HIV Managment in Australasia: A Guide to Clinical Management. Darlinghurst: Australasian Society of HIV Medicine; 2009. http://www.ashm.org.au/images/Publications/Monographs/HIV- Management-Australasia/hiv-managementmono-WHOLE.pdf. Accessed May 13, 2010.
8. Moreno S, Miralles C, Negredo E, et al. Disorders of body fat distribution in HIV-1-infected patients. AIDS Rev. 2009;11(3):126-134.
9. Haskell WL, Lee IM, Pate RR, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc. 2007;39(8):1423-1434.
10. Dubé M P, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003;37(5):613-627.
11. Nixon S, O'Brien K, Glazier RH, Tynan AM. Aerobic exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev. 2002(2): CD001796.
12. O'Brien K, Nixon S, Glazier RH, Tynan AM. Progressive resistive exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev. 2004(4):CD004248.
13. PEDro Scale. Physiotherapy Evidence Web site. September 6, 2010. http://www.pedro.fhs.usyd.edu.au/sacle-item.html. Accessed November 2009.
14. Baigis J, Korniewicz DM, Chase G, Butz A, Jacobson D, Wu AW. Effectiveness of a home-based exercise intervention for HIV-infected adults: a randomized trial. J Assoc Nurses AIDS Care. 2002;13(2):33-45.
15. Hand GA, Phillips KD, Dudgeon WD, et al. Moderate intensity exercise training reverses functional aerobic impairment in HIV-infected individuals AIDS Care. 2008;20(9):1066-1074.
16. Galantino ML, Shepard K, Krafft L, et al. The effect of group aerobic exercise and t'ai chi on functional outcomes and quality of life for persons living with acquired immunodeficiency syndrome. J Altern Complement Med. 2005;11(6):1085-1092.
17. LaPerriere AR, Antoni MH, Schneiderman N, et al. Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1. Biofeedback Self Regul. 1990;15(3):229-242.
18. LaPerriere A, Fletcher MA, Antoni MH, Klimas NG, Ironson G, Schneiderman N. Aerobic exercise training in an AIDS risk group. Int J Sports Med. 1991;12(Suppl 1):S53-57.
19. Rigsby LW, Dishman RK, Jackson AW, Maclean GS, Raven PB. Effects of exercise training on men seropositive for the human immunodeficiency virus-1. Med Sci Sports Exerc. 1992;24(1):6-12.
20. MacArthur RD, Levine SD, Birk TJ. Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons. Med Sci Sports Exerc. 1993;25(6):684-688.
21. Stringer WW, Berezovskaya M, O'Brien WA, Beck CK, Casaburi R. The effect of exercise training on aerobic fitness, immune indices, and quality of life in HIV+ patients. Med Sci Sports Exerc. 1998;30(1):11-16.
22. Jones S P, Doran DA, Leatt PB, Maher B, Pirmohamed M. Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy. AIDS (Lond). 2001;15(15):2049-2051.
23. Roubenoff R, Wilson IB. Effect of resistance training on self-reported physical functioning in HIV infection. Med Sci Sports Exerc. 2001;33(11):1811-1817.
24. Phillips EJ, Ottaway CA, Freedman J, et al. The effect of exercise on lymphocyte redistribution and leucocyte function in asymptomatic HIV-infected subjects. Brain Behav Immun. 1997;11(3):217-227.
25. Rojas R, Schlicht W, Hautzinger M. Effects of exercise training on quality of life, psychological well-being, immune status, and cardiopulmonary fitness in an HIV-1 positive population. J Sport Exerc Psychol. 2003;25(4).
26. Neidig JL, Smith BA, Brashers DE. Aerobic exercise training for depressive symptom management in adults living with HIV infection. J Assoc Nurses AIDS Care. 2003;14(2):30-40.
27. Mutimura E, Stewart A, Crowther NJ, Yarasheski KE, Cade WT. The effects of exercise training on quality of life in HAART-treated HIV-positive Rwandan subjects with body fat redistribution. Qual Life Res. 2008;17(3):377-385.
28. Lox C, McAuley E, Tucker R. Exercise as an intervention for enhancing subjective well-being in an HIV-1 population. J Sport Exerc Psychol. 1995;17:345-362.
29. Fillipas S, Oldmeadow LB, Bailey MJ, Cherry CL. A sixmonth, supervised, aerobic and resistance exercise program improves self-efficacy in people with human immunodeficiency virus: a randomised controlled trial. Aust J Physiother. 2006;52(3):185-190.
30. Dolan SE, Frontera W, Librizzi J, et al. Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus: a randomized trial. Arch Intern Med. 2006;166(11):1225-1231.
31. Smith BA, Neidig JL, Nickel JT, Mitchell GL, Para M F, Fass RJ. Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults. AIDS (Lond). 2001;15(6):693-701.
32. Lindegaard B, Hansen T, Hvid T, et al. The effect of strength and endurance training on insulin sensitivity and fat distribution in human immunodeficiency virus-infected patients with lipodystrophy. J Clin Endocrinol Metab. 2008;93(10):3860-3869.
33. Mutimura E, Crowther NJ, Cade TW, Yarasheski KE, Stewart A. Exercise training reduces central adiposity and improves metabolic indices in HAART-treated HIV-positive subjects in Rwanda: a randomized controlled trial. AIDS Res Hum Retroviruses. 2008;24(1):15-23.
34. Spence DW, Galantino ML, Mossberg KA, Zimmerman SO. Progressive resistance exercise: effect on muscle function and anthropometry of a select AIDS population. Arch Phys Med Rehabil. 1990;71(9):644-648.
35. Lox CL, McAuley E, Tucker RS. Aerobic and resistance exercise training effects on body composition, muscular strength, and cardiovascular fitness in an HIV-1 population. Int J Behav Med. 1996;3(1):55-69.
36. Perna FM, LaPerriere A, Klimas N, et al. Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infection. Med Sci Sports Exerc. 1999;31(7):973-979.
37. Terry L, Sprinz E, Ribeiro J P. Moderate and high intensity exercise training in HIV-1 seropositive individuals: a randomized trial. Int J Sports Med. 1999;20(2):142-146.
38. Malita FM, Karelis AD, Toma E, Rabasa-Lhoret R. Effects of different types of exercise on body composition and fat distribution in HIV-infected patients: a brief review. Canadian J Appl Physiol [Revue canadienne de physiologie appliquee]. 2005;30(2):233-245.
39. Halbert JA, Silagy CA, Finucane P, Withers RT, Hamdorf PA. Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: a meta-analysis of randomized, controlled trials. Eur J Clin Nutr. 1999;53(7):514-522.
40. Thoni GJ, Fedou C, Brun J F, et al. Reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia. Diabetes Metabol. 2002;28(5):397-404.
41. Fletcher G F, Balady G, Blair SN, et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans. A statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1996;94(4):857-862.
42. Pollock ML, Franklin BA, Balady GJ, et al. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: an advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation. 2000;101(7):828-833.
43. Ryan AS, Treuth MS, Rubin MA, et al. Effects of strength training on bone mineral density: hormonal and bone turnover relationships. J Appl Physiol. 1994;77(4):1678-1684.
44. Shipp KM. Exercise for people with osteoporosis: translating the science into clinical practice. Curr Osteoporos Rep. 2006;4(4):129-133.
45. Bongiovanni M, Tincati C. Bone diseases associated with human immunodeficiency virus infection: pathogenesis, risk factors and clinical management. Curr Mol Med. 2006;6(4):395-400.
46. Jacobson DL, Spiegelman D, Knox TK, Wilson IB. Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study. J Acquir Immune Defic Syndr. 2008;49(3):298-308.
47. Roubenoff R, Weiss L, McDermott A, et al. A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution. AIDS (Lond). 1999;13(11):1373-1375.
48. Roubenoff R, McDermott A, Weiss L, et al. Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus. AIDS (Lond). 1999;13(2):231-239.
49. Shen W, Wang Z, Punyanita M, et al. Adipose tissue quantification by imaging methods: a proposed classification. Obes Res. 2003;11(1):5-16.
50. Layne JE, Nelson ME. The effects of progressive resistance training on bone density: a review. Med Sci Sports Exerc. 1999;31(1):25-30.
51. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726-732.
52. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. Department of Health and Human Services. December 1, 2009;1-161. http:www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed December 2009.